Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FDA taking a year for IBRX review

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Nov 11, 2022 4:28pm

128 Views

Post# 35092614

RE:RE:RE:RE:RE:FDA taking a year for IBRX review

Do you know the definition of "definaition"

If you had consulted the corporate presentation instead of being insecure and start discussions on why a po ...
____________

FGPstock - (11/11/2022 3:24:58 PM)

RE:RE:RE:RE:FDA taking a year for IBRX review

do you know the definaition of "receive"?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in